# Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma

> **NCT06384950** · NA · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 450 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **BEHAVIORAL:** ChatGPT
- **BEHAVIORAL:** patient education with traditional methods.

## Key facts

- **NCT ID:** NCT06384950
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-22
- **Primary completion:** 2024-11-29
- **Final completion:** 2025-03-21
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06384950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06384950, "Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06384950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*